Breaking News, Collaborations & Alliances

Novavax, Xcellerex in H1N1 Vax Pact

Xcellerex will help Novavax manufacture new H1N1 flu vaccine

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Novavax and Xcellerex have entered into a strategic collaboration to accelerate the development of Novavax’s vaccine manufacturing process to commercial scale and begin immediate production of a novel 2009 H1N1 flu vaccine. The two companies will utilize Novavax’s unique virus-like particle (VLP) vaccine technology to produce initial commercial quantities of H1N1 vaccine with Xcellerex’s FlexFactory biomanufacturing platform. Xcellerex will provide development expertise and pro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters